MAPT and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease models, aberrant activation of GSK-3β has been associated with tau hyperphosphorylation, disrupting microtubule stability and thereby accelerating neurodegeneration (Li et al., 2014; Jin et al., 2015).